Doximity, Inc. $DOCS Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC reduced its position in Doximity, Inc. (NASDAQ:DOCS) by 2.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,647 shares of the company’s stock after selling 435 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Doximity were worth $1,082,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after acquiring an additional 990,923 shares in the last quarter. Invesco Ltd. increased its holdings in Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after purchasing an additional 696,923 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after purchasing an additional 1,113,076 shares during the period. Fuller & Thaler Asset Management Inc. increased its holdings in Doximity by 9.5% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company’s stock worth $100,408,000 after purchasing an additional 150,574 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Doximity by 8.2% during the 1st quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company’s stock worth $66,033,000 after purchasing an additional 86,135 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have weighed in on DOCS shares. Piper Sandler upped their price target on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Evercore ISI upped their price target on Doximity from $75.00 to $81.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. KeyCorp upped their price target on Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Truist Financial upped their price target on Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a report on Thursday, July 17th. Finally, Canaccord Genuity Group increased their price objective on Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $69.37.

Doximity Stock Up 3.0%

NASDAQ:DOCS opened at $67.60 on Tuesday. The stock’s 50 day moving average price is $68.65 and its 200 day moving average price is $61.02. The company has a market capitalization of $12.66 billion, a PE ratio of 67.60, a P/E/G ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 52-week low of $40.87 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $70.50, for a total value of $352,500.00. Following the transaction, the director owned 19,839 shares in the company, valued at $1,398,649.50. This represents a 20.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,000 shares of company stock worth $2,281,680 in the last quarter. 31.30% of the stock is owned by insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.